AL
HAE icon

AJO LP’s Haemonetics HAE Stock Holding History

AJO LP’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,030
Closed -$1.4M – 741
2020
Q1 		$1.4M Buy
+14,030
New +$1.52M 0.01% 382
2019
Q1 		– Sell
-13,853
Closed -$1.39M – 687
2018
Q4 		$1.39M Sell
13,853
-130,454
-90% -$13.7M 0.01% 484
2018
Q3 		$16.5M Sell
144,307
-16,683
-10% -$1.73M 0.08% 197
2018
Q2 		$14.4M Sell
160,990
-709,761
-82% -$59.9M 0.07% 206
2018
Q1 		$63.7M Sell
870,751
-12,743
-1% -$874K 0.29% 106
2017
Q4 		$51.3M Buy
+883,494
New +$46.5M 0.22% 119

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP's HAE Position: Q2 2020 in Review

AJO LP sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 14,030 shares — an estimated $1.4M sold.

AJO LP first reported a position in HAE in Q4 2017 and held it in 6 quarters. The position peaked at $63.7M in Q1 2018. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

  • AJO LP reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
  • AJO LP sold 14,030 Haemonetics shares in Q2 2020, an estimated $1.4M.
  • AJO LP first reported a position in Haemonetics in Q4 2017 and held it in 6 quarters.
  • AJO LP's Haemonetics position peaked at $63.7M in Q1 2018.
  • 285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on AJO LP's 13F filing for Q2 2020, filed 12 Aug 2020.